WASHINGTON DC USA -- HEALTHCARE UPDATE NEWS SERVICE™ -- DECEMBER 11, 2020: Please join the Alliance for Health Policy, our partners, and experts for a timely discussion on the distribution of COVID-19 vaccines.

The COVID-19 pandemic sparked international concern about vulnerabilities in the global supply chain and disrupted the production of crucial pharmaceutical ingredients around the world. In a strained, but resilient market, two promising vaccine candidates boasting nearly 95% effectiveness rose to the top of various formulations. While their sponsors seek Emergency Use Authorization (EUA) from the Food and Drug Administration, the rest of the American health care system is preparing for vaccine deployment and mass immunization. This briefing will explore how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists will also illustrate the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.

Complimentary Webinar: From Bench to Body:
How the U.S. Health Care System Plans to Distribute COVID-19 Vaccines

December 16, 2020 | 4:00 - 5:00 p.m. EST

EXPERT PANELISTS INCLUDE
Esther Krofah, MPP Executive Director, FasterCures, a Center of the Milken Institute	Litjen (L.J.) Tan, M.S., Ph.D. Chief Strategy Officer, Immunization Action Coalition
Hemi Tewarson, MPH, J.D. Visiting Senior Policy Fellow, Duke-Margolis Center for Health Policy	Sarah J. Dash, MPH (moderator) President and CEO, Alliance for Health Policy

The Alliance for Health Policy gratefully acknowledges the support of Arnold Ventures, The Commonwealth Fund, and the National Institute of Health Care Management (NIHCM) for this event.